1-5 of 5
Simona Colla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EZH2 Inhibitors: The Unpacking Revolution

Vera Adema, Simona Colla
Journal: Cancer Research
Cancer Res (2022) 82 (3): 359–361.
https://doi.org/10.1158/0008-5472.CAN-21-4311
Published: 02 February 2022
View article titled, EZH2 Inhibitors: The Unpacking Revolution
Open the PDF for EZH2 Inhibitors: The Unpacking Revolution in another window
Journal Articles

Abstract 5033: Clonal origin of therapy-related myeloid neoplasms

Koichi Takahashi, Feng Wang, Hagop Kantarjian, Doss Denaha, Erika Thompson, Curtis Gumbs, Keyur Patel, Sattva Neelapu, Yan Wang, Zachary Bohannan, Courtney DiNardo, Farhad Ravandi, Zeev Estrov, Simona Colla, Jianhua Zhang, Xifeng Wu, Guillermo Garcia-Manero, Andrew Futreal
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 5033.
https://doi.org/10.1158/1538-7445.AM2016-5033
Published: 15 July 2016
View article titled, Abstract 5033: Clonal origin of therapy-related myeloid neoplasms
Journal Articles

Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer

Piergiorgio Pettazzoni, Andrea Viale, Parantu Shah, Alessandro Carugo, Haoqiang Ying, Huamin Wang, Giannicola Genovese, Sahil Seth, Rosalba Minelli, Tessa Green, Emmet Huang-Hobbs, Denise Corti, Nora Sanchez, Luigi Nezi, Matteo Marchesini, Avnish Kapoor, Wantong Yao, Maria E. Di Francesco, Alessia Petrocchi, Angela K. Deem, Kenneth Scott, Simona Colla, Gordon B. Mills, Jason B. Fleming, Timothy P. Heffernan, Philip Jones, Carlo Toniatti, Ronald A. DePinho, Giulio F. Draetta
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (6): 1091–1101.
https://doi.org/10.1158/0008-5472.CAN-14-1854
Published: 12 March 2015
View article titled, Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer
Open the PDF for Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3α and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions

Nicola Giuliani, Gina Lisignoli, Simona Colla, Mirca Lazzaretti, Paola Storti, Cristina Mancini, Sabrina Bonomini, Cristina Manferdini, Katia Codeluppi, Andrea Facchini, Vittorio Rizzoli
Journal: Cancer Research
Cancer Res (2008) 68 (16): 6840–6850.
https://doi.org/10.1158/0008-5472.CAN-08-0402
Published: 12 August 2008
View article titled, CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3α and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions
Open the PDF for CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3α and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions in another window
Journal Articles

Do Human Myeloma Cells Directly Produce the Receptor Activator of Nuclear Factor κB Ligand (RANKL) or Induce RANKL in the Bone Marrow Microenvironment?

Nicola Giuliani, Simona Colla, Vittorio Rizzoli, Sophie Barillé-Nion, Régis Bataille
Journal: Cancer Research
Cancer Res (2004) 64 (2): 772–773.
https://doi.org/10.1158/0008-5472.772.64.2
Published: 26 January 2004
View article titled, Do Human Myeloma Cells Directly Produce the Receptor Activator of Nuclear Factor κB Ligand (RANKL) or Induce RANKL in the Bone Marrow Microenvironment?
Open the PDF for Do Human Myeloma Cells Directly Produce the Receptor Activator of Nuclear Factor κB Ligand (RANKL) or Induce RANKL in the Bone Marrow Microenvironment? in another window